The drugmaker Pfizer/BioNTech today assured that the vaccine against Covid-19 is safe in children over 5 years, with almost 91% effectiveness in preventing infection.
Details of the study were published today. online and US regulators are already considering opening vaccination to young people between the ages of 5 and 11, according to the Associated Press (AP) news agency.
According to the AP, administration of the vaccine could begin in early November, if regulators give the green light to the process.
In case the vaccination progresses on this date, the first children to be vaccinated will already be fully protected at Christmas.
The Food and Drug Administration (FDA), the US health regulator, is to publish later today the initial analysis of the company's safety and efficacy data on the vaccine.
Next week, FDA advisers will publicly debate the information, APP said.
If the FDA authorizes low-dose injections, the Centers for Disease Control and Prevention will make the final recommendations on who should receive them.
Pfizer's vaccine is licensed for ages 12 and up, but pediatricians and many parents are eagerly awaiting protection for younger children to contain the growing infections of the very contagious delta variant and help keep children in school.
Comments